Isoniazid [clinicaltrials_resource:b47e0083d86e6576a506df1304d91881]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [clinicaltrials:NCT00000636]Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [clinicaltrials:NCT00000638]A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin [clinicaltrials:NCT00000778]A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients. [clinicaltrials:NCT00000796]Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis [clinicaltrials:NCT00000950]Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection [clinicaltrials:NCT00000959]The Treatment of Tuberculosis in HIV-Infected Patients [clinicaltrials:NCT00001033]Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users [clinicaltrials:NCT00004740]TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis [clinicaltrials:NCT00023335]TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB [clinicaltrials:NCT00023348]clinicaltrials:NCT00023374clinicaltrials:NCT00023452clinicaltrials:NCT00080119clinicaltrials:NCT00128206clinicaltrials:NCT00130247A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts [clinicaltrials:NCT00130325]clinicaltrials:NCT00144417clinicaltrials:NCT00164281TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection [clinicaltrials:NCT00164450]TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment [clinicaltrials:NCT00164463]Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9) [clinicaltrials:NCT00170209]clinicaltrials:NCT00293228Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT) [clinicaltrials:NCT00298870]Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children [clinicaltrials:NCT00330304]clinicaltrials:NCT00351702clinicaltrials:NCT00376012clinicaltrials:NCT00396084Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection [clinicaltrials:NCT00397709]Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis [clinicaltrials:NCT00402454]A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy [clinicaltrials:NCT00402610]Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons [clinicaltrials:NCT00463086]clinicaltrials:NCT00495651High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis [clinicaltrials:NCT00513396]Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2) [clinicaltrials:NCT00571753]clinicaltrials:NCT00728507clinicaltrials:NCT00728546clinicaltrials:NCT00737724Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison [clinicaltrials:NCT00767975]clinicaltrials:NCT00816426Feasibility and Effectiveness of Community Based Isoniazid Preventive Therapy in Kenya [clinicaltrials:NCT00850915]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Isoniazid [clinicaltrials_resource:b47e0083d86e6576a506df1304d91881]
Bio2RDF identifier
b47e0083d86e6576a506df1304d91881
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b47e0083d86e6576a506df1304d91881
identifier
clinicaltrials_resource:b47e0083d86e6576a506df1304d91881
title
Isoniazid
@en
type
label
Isoniazid [clinicaltrials_resource:b47e0083d86e6576a506df1304d91881]
@en